Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] - N0000193926

Pharmacologic Code	N0000193926
Pharmacologic Name	Insulin-like Growth Factor-1 Receptor Inhibitor
Pharmacologic Uses	insulin-like growth factor-1 receptor inhibitor
Pharmacologic Concept	Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description	An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions: A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication. A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

The table contains 1 products whose active ingredient are classified under the same pharmacologic class Insulin-like Growth Factor-1 Receptor Inhibitor [EPC].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	75987-130	Tepezza	Non-Proprietary Name: Teprotumumab	Injection, Powder, Lyophilized, For Solution	Intravenous	Horizon Therapeutics Usa, Inc.	ACTIVE